Shi Qianling, Wang Zijun, Liu Jiao, Wang Xingmei, Zhou Qi, Li Qinyuan, Yu Yang, Luo Zhengxiu, Liu Enmei, Chen Yaolong
The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China.
Lanzhou University Institute of Health Data Science, Lanzhou 730000, China.
EClinicalMedicine. 2021 Nov;41:101155. doi: 10.1016/j.eclinm.2021.101155. Epub 2021 Oct 19.
This study provides the first systematic review and meta-analysis to identify the predictors of unfavorable prognosis of COVID-19 in children and adolescents.
We searched literature databases until July 2021 for studies that investigated risk factors for unfavorable prognosis of children and adolescents with COVID-19. We used random-effects models to estimate the effect size with 95% confidence interval ().
We identified 56 studies comprising 79,104 individuals. Mortality was higher in patients with multisystem inflammatory syndrome (MIS-C) (odds ratio []=58.00, 95% 6.39-526.79) and who were admitted to intensive care (=12.64, 95% 3.42-46.68). Acute respiratry distress syndrme (ARDS) (=29.54, 95% 12.69-68.78) and acute kidney injury (AKI) (=55.02, 95% 6.26-483.35) increased the odds to be admitted to intensive care; shortness of breath (=16.96, 95% 7.66-37.51) increased the need of respiratory support; and neurological diseases (=5.16, 95% 2.30-11.60), C-reactive protein (CRP) level ≥80 mg/L (=11.70, 95% 4.37-31.37) and D-dimer level ≥0.5ug/mL (=20.40, 95% 1.76-236.44) increased the odds of progression to severe or critical disease.
Congenital heart disease, chronic pulmonary disease, neurological diseases, obesity, MIS-C, shortness of breath, ARDS, AKI, gastrointestinal symptoms, elevated CRP and D-dimer are associated with unfavourable prognosis in children and adolescents with COVID-19.
本研究首次进行系统评价和荟萃分析,以确定儿童和青少年新冠病毒病(COVID-19)预后不良的预测因素。
我们检索了截至2021年7月的文献数据库,以查找调查儿童和青少年COVID-19预后不良风险因素的研究。我们使用随机效应模型来估计效应大小及95%置信区间()。
我们纳入了56项研究,共79104例个体。多系统炎症综合征(MIS-C)患者的死亡率更高(比值比[]=58.00,95% 6.39 - 526.79),入住重症监护病房的患者死亡率也更高(=12.64,95% 3.42 - 46.68)。急性呼吸窘迫综合征(ARDS)(=29.54,95% 12.69 - 68.78)和急性肾损伤(AKI)(=55.02,95% 6.26 - 483.35)增加了入住重症监护病房的几率;呼吸急促(=16.96,95% 7.66 - 37.51)增加了呼吸支持的需求;神经疾病(=5.16,95% 2.30 - 11.60)、C反应蛋白(CRP)水平≥80mg/L(=11.70,95% 4.37 - 31.37)和D-二聚体水平≥0.5μg/mL(=20.40,95% 1.76 - 236.44)增加了进展为重症或危重症疾病的几率。
先天性心脏病、慢性肺病、神经疾病、肥胖、MIS-C、呼吸急促、ARDS、AKI、胃肠道症状、CRP和D-二聚体升高与儿童和青少年COVID-19预后不良相关。